澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

GENETIC SIGNATURES LTD

0.073

-0.008-9.88%

成交量：22.70萬

成交額：1.73萬

市值：1,658.11萬

市盈率：-1.18

高：0.080

開：0.080

低：0.073

收：0.081

52周最高：0.430

52周最低：0.051

股本：2.27億

流通股本：1.88億

量比：1.48

換手率：0.12%

股息：- -

股息率：- -

每股收益(TTM):-0.062

每股收益(LYR):-0.062

淨資產收益率：-32.64%

總資產收益率：-17.27%

市淨率：0.46

市盈率(LYR):-1.18

資料載入中...

總覽公司新聞資訊公告

BCAL診斷公司：要求罷免Michael Aicher，並提名Forrester與Melki進入GSS董事會

遺傳特徵公司要求BCAL診斷澄清其在GSS的持股及關聯方詳情

基因標記公司：合併集團有望憑藉精簡成本基礎與潛在加速增長受益

BCAL Diagnostics將收購Genetic Signatures股份

GENETIC SIGNATURES LTD澄清：未收到亦未向ASX提交與Bcal公告相關的股份收購重大持股人通知

GENETIC SIGNATURES LTD表示無法對BCAL意圖置評，僅以BCAL公告內容為準

GENETIC SIGNATURES LTD確認對先前公告中提及的股份收購提議事先不知情

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/GSS.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.073,"timestamp":1789452720000,"preClose":0.081,"halted":0,"volume":226967,"delay":0,"changeRate":-0.09876543209876551,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.0617,"marketStatus":"未開盤","change":-0.008,"latestTime":"09-15 16:12:00 AEST","open":0.08,"high":0.08,"low":0.073,"amount":17260,"amplitude":0.08642,"askPrice":0.085,"askSize":39647,"bidPrice":0.072,"bidSize":40000,"shortable":3,"etf":0,"ttmEps":-0.0617,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.081,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":1.475333,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"GSS.AU","preClose":0.081,"auctionPrice":0.073,"auctionVolume":12906,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452591347}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-17.27%","roe":"-32.64%","lyrEps":-0.0617,"volumeRatio":1.475333,"shares":227138828,"dividePrice":0,"high":0.08,"amplitude":0.08642,"preClose":0.081,"low":0.073,"week52Low":0.051,"pbRate":"0.46","psRate":"0.86","week52High":0.43,"institutionHeld":0,"latestPrice":0.073,"committee":0.004432,"eps":-0.0617,"divideRate":0,"volume":226967,"delay":0,"ttmEps":-0.0617,"open":0.08,"prevYearClose":0.25,"prevWeekClose":0.08,"prevMonthClose":0.095,"prevQuarterClose":0.067,"fiveDayClose":0.087,"twentyDayClose":0.061,"sixtyDayClose":0.065,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787616000000,"name":null,"time":"","dateTimestamp":1787580000000,"actualEps":null},{"date":"2026-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1173556031","title":"BCAL診斷公司：要求罷免Michael Aicher，並提名Forrester與Melki進入GSS董事會","url":"https://stock-news.laohu8.com/highlight/detail?id=1173556031","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173556031?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 10:42","pubTimestamp":1788403333,"startTime":"0","endTime":"0","summary":"BCAL诊断有限公司已正式提出动议，要求将Michael Aicher从Genetic Signatures Ltd董事会中罢免。与此同时，该公司还力荐Forrester及Melki两位候选人，以期他们能够顺利加入GSS董事会。这一人事调整举措，无疑为GSS公司的治理结构投下了一枚重磅炸弹。BCAL方面显然希望通过此番运作，重塑董事会的权力格局，注入新鲜血液。BCAL此举的深层动因，以及新任董事若顺利上位后将带来怎样的治理新风，均有待市场的进一步观察与解读。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BDX.AU","BK7501","GSS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115211142","title":"遺傳特徵公司要求BCAL診斷澄清其在GSS的持股及關聯方詳情","url":"https://stock-news.laohu8.com/highlight/detail?id=1115211142","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115211142?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 07:39","pubTimestamp":1788392350,"startTime":"0","endTime":"0","summary":"遗传特征有限公司（Genetic Signatures Ltd, GSS.AU）已正式向BCAL诊断有限公司（BCAL Diagnostics Ltd, BDX.AU）发出请求，要求后者就其在该公司的持股情况以及关联方关系提供更为详尽的说明。\n据悉，此项请求涉及BCAL诊断在遗传特征公司中的股东身份及相关联方细节，但具体交易背景及可能引发的后续影响尚未对外披露。市场参与人士正密切关注事态发展，以评估这一动向可能对两家澳大利亚医疗诊断领域企业带来的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7501","GSS.AU","BK7067","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125560310","title":"基因標記公司：合併集團有望憑藉精簡成本基礎與潛在加速增長受益","url":"https://stock-news.laohu8.com/highlight/detail?id=1125560310","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125560310?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 07:36","pubTimestamp":1787700997,"startTime":"0","endTime":"0","summary":"基因标记公司——合并后的集团预计将从精简的成本结构中获益，并可能迎来增长加速的契机。市场分析人士指出，成本基础的收窄不仅有助于提升盈利能力，更为潜在的扩张机遇创造了有利条件。值得注意的是，合并后实体的协同效应有望在中期内逐步显现，从而推动业绩增长轨迹向上修正。简而言之，这一变革性举措预示着集团将步入一个更加精简、高效且具备增长动能的新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU","BK7124","BK7501","BK7048","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182337442","title":"BCAL Diagnostics將收購Genetic Signatures股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1182337442","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182337442?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 16:48","pubTimestamp":1783414100,"startTime":"0","endTime":"0","summary":"7月2日——BCAL Diagnostics有限公司宣布，将收购GENETIC SIGNATURES有限公司的股份。具体而言，BCAL将以139万澳元的价格，收购GENETIC SIGNATURES公司10.2%的股权。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX.AU","GSS.AU","BK7048","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183625175","title":"GENETIC SIGNATURES LTD澄清：未收到亦未向ASX提交與Bcal公告相關的股份收購重大持股人通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1183625175","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183625175?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 12:45","pubTimestamp":1782967543,"startTime":"0","endTime":"0","summary":"GENETIC SIGNATURES LTD发布澄清声明，表示公司并未收到，也未向澳大利亚证券交易所（ASX）提交任何与Bcal公告中所提及的股份收购相关的重大持股人通知。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152360294","title":"GENETIC SIGNATURES LTD表示無法對BCAL意圖置評，僅以BCAL公告內容為準","url":"https://stock-news.laohu8.com/highlight/detail?id=1152360294","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152360294?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 12:42","pubTimestamp":1782967368,"startTime":"0","endTime":"0","summary":"GENETIC SIGNATURES LTD明确指出，对于BCAL的意图，除BCAL自身公告中的声明外，公司无法提供任何进一步评论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7048","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197336969","title":"GENETIC SIGNATURES LTD確認對先前公告中提及的股份收購提議事先不知情","url":"https://stock-news.laohu8.com/highlight/detail?id=1197336969","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197336969?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 12:42","pubTimestamp":1782967368,"startTime":"0","endTime":"0","summary":"GENETIC SIGNATURES LTD已确认，对于先前公告中所提及的股份收购提议，公司方面事先并不知情。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}